Latest News of VRA
Analysts Have Made A Financial Statement On Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Third-Quarter Report
By Yahoo! Finance |
1 week ago
Analysts were overly optimistic on Zevra Therapeutics (NASDAQ: ZVRA) as it underperformed in Q3. Despite revenue growth predictions for 2025, ongoing losses affect valuation. Forecasts indicate the co...
How the NFL playoff picture could change, plus where Belichick and Vrabel could land
By The New York Times |
1 week ago
The Athletic's Mike Sando shared his QB Betrayal Index, focusing on quarterbacks overcoming poor defense and special teams. Teams like the Jaguars, Seahawks, Saints, and Vikings fell short last season...
Bill Belichick, Mike Vrabel, Deion Sanders top star-studded 2025 NFL head coach candidate list
By The New York Times |
1 week ago
The NFL is in the midst of a coaching shakeup, with notable candidates like Belichick, Vrabel, and McCarthy in the mix. Other potential hires include Joseph, Johnson, and Sanders, bringing diverse bac...
-
Zevra Therapeutics Inc (ZVRA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ...
By Yahoo! Finance | 1 week agoThe CEO and Chief Commercial Officer provided updates on the manufacturing and distribution timeline for Myle, emphasizing on-time progress and no reimbursement hurdles. They discussed expectations fo...
-
Who Is Scott McGillivray's Wife? All About Sabrina McGillivray
By PEOPLE.com | 2 weeks agoScott McGillivray, a home renovation expert, and his wife, Sabrina, share a deep bond. Sabrina, a teacher and mom, plays a crucial role in their family life. They celebrate love and family, with Scott...
-
Jets head coaching candidates: From Vrabel to Ulbrich, Ben Johnson to Rex Ryan
By The New York Times | 3 weeks agoThe New York Jets may be in need of a new head coach, quarterback, and general manager soon. Potential coaching candidates include Mike Vrabel, Pete Carroll, Kliff Kingsbury, Brian Flores, and more, a...
-
The Glimpse Group, Inc. (VRAR): Among The Best Augmented Reality Stocks Under $5
By Yahoo! Finance | 1 month agoA list of top augmented reality stocks under $5 is analyzed, with The Glimpse Group, Inc. (NASDAQ:VRAR) highlighted. The integration of AR in autonomous vehicles and healthcare is discussed, along wit...
-
Savara Inc. (SVRA) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 1 month agoSavara Inc. has introduced the Savara Early Access Program for aPAP patients, providing molgramostim through an Expanded Access Program in specific regions lacking commercial availability, following l...
-
Vera Bradley Inc (VRA) Q2 2025 Earnings Call Transcript Highlights: Navigating Challenges and ...
By Yahoo! Finance | 1 month agoThe earnings call discussed challenges among lower-income consumers and plans for new wholesale partnerships. Despite negative free cash flow in the first half, the company expects improvement and wil...
-
Jakub Vrana is back in camp with the Capitals looking to show he can still play in the NHL
By AP NEWS | 1 month agoJakub Vrana, a skilled NHL winger, is determined to overcome past challenges and secure a spot on the Washington Capitals roster. With support from teammates and coaches, he is focused on showcasing h...
-
20 Years Of Vranec At Chateau Kamnik, A Talk With The Winemaker
By Forbes | 1 month agoChateau Kamnik in North Macedonia is renowned for producing quality Vranec wines. Winemaker Sandra Krstevska elaborates on the challenges and rewards of working with this unique Balkan grape, known fo...
-
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
By Yahoo! Finance | 2 months agoMiplyffa, in combination with Johnson & Johnson's enzyme inhibitor Zavesca, is approved by the FDA to treat neurological symptoms in adults and children with NPC, a rare genetic disease. This marks a ...
-
US FDA approves Zevra's treatment for rare genetic disease
By Yahoo! Finance | 2 months agoThe U.S. FDA approved Zevra Therapeutics' drug for Neimann-Pick disease type C, a rare genetic disorder. The oral drug, Miplyffa, can now be used in combination with miglustat to treat neurological sy...
-
Savara, Inc. (SVRA): The Best Multibagger Penny Stock of 2025?
By Yahoo! Finance | 2 months agoThe article discusses the concept of multibagger penny stocks and evaluates Savara, Inc. (NASDAQ:SVRA) in this context. It highlights the potential of Savara's lead therapy, molgramostim, for treating...
-
VRAX Stock Price | Virax Biolabs Group Ltd. Stock Quote (U.S.: Nasdaq) | MarketWatch
By MarketWatch | 3 months agoVirax Biolabs Group Ltd. is a London-based holding company founded in 2013 by James Foster and Cameron Shaw. It specializes in selling diagnostics test kits, med-tech, and personal protective equipmen...